Maravai LifeSciences (MRVI) News Today → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free MRVI Stock Alerts $10.53 +0.07 (+0.67%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 8:00 AM | businesswire.comTriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation CenterMay 13 at 3:24 AM | americanbankingnews.comRobert W. Baird Raises Maravai LifeSciences (NASDAQ:MRVI) Price Target to $10.00May 11 at 5:40 PM | marketbeat.comMonaco Asset Management SAM Makes New Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Monaco Asset Management SAM acquired a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 311,210 shareMay 10, 2024 | finance.yahoo.comMaravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | americanbankingnews.comMaravai LifeSciences (NASDAQ:MRVI) Trading Up 6% After Analyst UpgradeMay 9, 2024 | finance.yahoo.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call TranscriptMay 9, 2024 | globenewswire.comMaravai LifeSciences Announces May and June 2024 Investor Conference ScheduleMay 9, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Up 6% After Analyst UpgradeMaravai LifeSciences (NASDAQ:MRVI) Shares Up 6% Following Analyst UpgradeMay 9, 2024 | marketbeat.comRobert W. Baird Increases Maravai LifeSciences (NASDAQ:MRVI) Price Target to $10.00Robert W. Baird upped their price objective on shares of Maravai LifeSciences from $8.00 to $10.00 and gave the stock an "outperform" rating in a research report on Thursday.May 9, 2024 | finance.yahoo.comMaravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights:May 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Arcus Biosciences (RCUS) and Maravai Lifesciences Holdings (MRVI)May 8, 2024 | msn.comMRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | seekingalpha.comMaravai LifeSciences Holdings, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 8, 2024 | globenewswire.comMaravai LifeSciences Reports First Quarter 2024 Financial ResultsMay 6, 2024 | americanbankingnews.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 5, 2024 | marketbeat.comFederated Hermes Inc. Sells 189,696 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Federated Hermes Inc. trimmed its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 80.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44April 30, 2024 | marketbeat.comSivik Global Healthcare LLC Acquires New Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Sivik Global Healthcare LLC bought a new position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 205,241 shares of the company's stock, valuedApril 30, 2024 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)April 30, 2024 | businesswire.comTriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping TechnologyApril 23, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Up 8.1%Maravai LifeSciences (NASDAQ:MRVI) Trading 8.1% HigherApril 18, 2024 | businesswire.comTriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionApril 18, 2024 | marketbeat.comMackenzie Financial Corp Boosts Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Mackenzie Financial Corp boosted its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 4.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,169,176 shares of the company's stock after buApril 17, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading Down 2.9%Maravai LifeSciences (NASDAQ:MRVI) Trading Down 2.9%April 17, 2024 | msn.comMaravai LifeSciences Holdings (MRVI) Price Target Increased by 6.78% to 9.98April 12, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Short Interest UpdateMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) saw a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 5,120,000 shares, a decrease of 30.3% from the March 15th total of 7,350,000 shares. Based on an average daily volume of 2,740,000 shares, the short-interest ratio is currently 1.9 days. Approximately 4.8% of the company's stock are sold short.April 11, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and seven haApril 10, 2024 | globenewswire.comMaravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024April 10, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Coverage Initiated by Analysts at Craig HallumCraig Hallum began coverage on Maravai LifeSciences in a research note on Wednesday. They set a "buy" rating and a $15.00 price objective on the stock.April 9, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading 4.6% Higher Maravai LifeSciences (NASDAQ:MRVI) Shares Up 4.6%April 5, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Down 3.3% Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 3.3%April 5, 2024 | marketbeat.comVanguard Group Inc. Sells 341,685 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Vanguard Group Inc. reduced its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 3.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,217,282 shares of the company's stock after selling 341,685 shares durMarch 27, 2024 | marketbeat.comPacer Advisors Inc. Acquires 810,957 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Pacer Advisors Inc. grew its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 37.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,955,230 shares of the company's stoMarch 21, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Sees Large Volume IncreaseMaravai LifeSciences (NASDAQ:MRVI) Sees Large Volume IncreaseMarch 19, 2024 | finance.yahoo.comShould You Sell Maravai LifeSciences (MRVI)?March 18, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Up 3.9%Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 3.9%March 14, 2024 | marketbeat.comHudson Bay Capital Management LP Acquires 416,876 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Hudson Bay Capital Management LP boosted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 171.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 659,397 shMarch 12, 2024 | finance.yahoo.comMRVI Apr 2024 2.500 callMarch 12, 2024 | globenewswire.comMaravai LifeSciences Announces March 2024 Investor Conference ScheduleMarch 11, 2024 | finance.yahoo.comMRVI Apr 2024 2.500 putMarch 8, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading Up 6.7%Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 6.7%March 7, 2024 | marketbeat.comAQR Capital Management LLC Has $17.21 Million Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)AQR Capital Management LLC boosted its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 80.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,749,003 shares of the company's stock after aMarch 4, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Acquired by Glenmede Trust Co. NAGlenmede Trust Co. NA lifted its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 163.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,108,554 shares of the companMarch 3, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is 12 West Capital Management LP's 7th Largest Position12 West Capital Management LP boosted its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 92.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,463,111 shares of the company's stock afteMarch 1, 2024 | marketbeat.comBraidwell LP Buys 2,170,157 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Braidwell LP lifted its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 120.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,974,857 shares of the company'sFebruary 26, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading Down 4.7% on Analyst DowngradeMaravai LifeSciences (NASDAQ:MRVI) Trading Down 4.7% on Analyst DowngradeFebruary 26, 2024 | marketbeat.comTrading was temporarily halted for "MRVI" at 09:02 AM with a stated reason of "LULD pause."February 26, 2024 | markets.businessinsider.comBuy Rating Affirmed for Maravai Lifesciences Amid Strong Financial Performance and Growth OutlookFebruary 25, 2024 | marketbeat.comEpoch Investment Partners Inc. Grows Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Epoch Investment Partners Inc. raised its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 36.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,541,591 shares of the company's stocFebruary 24, 2024 | uk.news.yahoo.com300 from RNAS Culdrose join largest NATO exercise since the Cold WarFebruary 24, 2024 | finance.yahoo.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… MRVI Media Mentions By Week MRVI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRVI News Sentiment▼0.300.57▲Average Medical News Sentiment MRVI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRVI Articles This Week▼183▲MRVI Articles Average Week Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DYN News GERN News ARDX News ARVN News RCKT News KROS News RYTM News DCPH News RNA News PTCT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRVI) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
